Discover how LAVImin measured by cardiac MRI outperformed traditional risk factors in predicting adverse outcomes after heart ...

At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.

Beta-blockers have been the initial treatment for symptomatic obstructive hypertrophic cardiomyopathy (HCM) despite limited evidence of their efficacy. Aficamten is a cardiac myosin inhibitor that ...